SCHEMBL16514436

SCHEMBL16514436

CN1CCN(c2ccc(Nc3ncc4cccc(-c5cccc(C=CC(N)=O)c5)c4n3)cc2F)CC1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.62
FGFR1 P11362 2/20 0.54
KDR P35968 2/20 0.54
BRD4 O60885 8/20 0.51
JAK2 O60674 4/20 0.51
FLT3 P36888 1/20 0.49
BTK Q06187 1/20 0.49
PAK1 Q13153 1/20 0.48
AXL P30530 1/20 0.47
JAK3 P52333 5/20 0.47
JAK1 P23458 4/20 0.47
BRDT Q58F21 2/20 0.47
BRD2 P25440 1/20 0.47
BRD3 Q15059 1/20 0.47
FGFR2 P21802 1/20 0.46
PIM2 Q9P1W9 1/20 0.46
SIK1 P57059 1/20 0.46
SIK2 Q9H0K1 1/20 0.46
SIK3 Q9Y2K2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16513994 0.92 EGFR (0.63) EGFRFGFR1KDRBRD4JAK2
SCHEMBL16514587 0.91 FGFR1 (0.55) EGFRFGFR1KDRBRD4JAK2
SCHEMBL16514550 0.90 EGFR (0.61) EGFRFGFR1KDRBRD4JAK2
SCHEMBL16513747 0.90 EGFR (0.61) EGFRFGFR1KDRBRD4JAK2
SCHEMBL18527542 0.89 EGFR (0.51) EGFRFGFR1KDRBRD4JAK2
SCHEMBL18527536 0.89 EGFR (0.51) EGFRFGFR1KDRBRD4JAK2
SCHEMBL18527541 0.89 EGFR (0.51) EGFRFGFR1KDRBRD4JAK2
SCHEMBL18527570 0.87 EGFR (0.52) EGFRFGFR1KDRBRD4JAK2
Maleic Acid SCHEMBL16514328 0.85 FGFR1 (0.56) EGFRFGFR1KDRBRD4JAK2
Fumaric Acid SCHEMBL16514259 0.85 FGFR1 (0.56) EGFRFGFR1KDRBRD4JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3035936-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS NeuPharma, Inc. (US) 2016-06-29 EP disclosed
WO-2015027222-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS NEUPHARMA, INC. (US) 2015-02-26 WO disclosed